Sp1196
HOW TO CREATE A BUSINESS CASE FOR IMPLEMENTATION AND GROWTH OF NEW TECHNOLOGY INTO A HOSPITAL SYSTEM
Date
May 9, 2023
Explore related products in the following collection:
Society: AGA
This session will provide attendees with the knowledge and skills to successfully create and implement new technology into their practices through negotiation with payors and securing support from hospital systems. Learn from experts in reimbursement and insurance negotiation, hear from payors what makes a persuasive case to cover new technology and apply the concepts from this seminar to create a business plan for successful adoption of third space endoscopy.
This session will provide attendees with the knowledge and skills to successfully create and implement new technology into their practices through negotiation with payors and securing support from hospital systems. Learn from experts in reimbursement and insurance negotiation, hear from payors what makes a persuasive case to cover new technology and apply the concepts from this seminar to create a business plan for successful adoption of third space endoscopy.
Presenter
Mayo Clinic-Jacksonville
Tracks
Related Products
INTRODUCTION
SOCIETY: AGA
CAN ESD REPLACE EMR IN THE GI TRACT? AN EVIDENCE-BASED ASSESSMENT
This clinical symposium will focus on the current state of the art for advanced tissue resection techniques (specifically ESD) and strategies for achieving the goal of reimbursement…
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
A NOVEL COMPUTER-AIDED POLYP DETECTION SYSTEM IN DAILY CLINICAL CARE: AN INTERNATIONAL MULTICENTER, RANDOMIZED, TANDEM TRIAL
INTRODUCTION: Although colonoscopy is considered the gold standard for detection and removal of premalignant polyps, up to 26% of lesions are missed in tandem studies. Computer-aided polyp detection (CADe) has shown promise in increasing polyp detection rates…
